List of Obsidian Therapeutics patents | 6 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 12104178 DHFR tunable protein regulation	Patent 12104178 was granted and assigned to Obsidian Therapeutics on October, 2024 by the United States Patent and Trademark Office.	Obsidian Therapeutics	Obsidian Therapeutics	United States Patent and Trademark Office	12104178	October 1, 2024
‌ US Patent 11058725 CA2 compositions and methods for tunable regulation	Patent 11058725 was granted and assigned to Obsidian Therapeutics on July, 2021 by the United States Patent and Trademark Office.	Obsidian Therapeutics	Obsidian Therapeutics	United States Patent and Trademark Office	11058725	July 13, 2021
‌ US Patent 11241485 PDE5 compositions and methods for immunotherapy	Patent 11241485 was granted and assigned to Obsidian Therapeutics on February, 2022 by the United States Patent and Trademark Office.	Obsidian Therapeutics	Obsidian Therapeutics	United States Patent and Trademark Office	11241485	February 8, 2022
‌ US Patent 11629340 DHFR tunable protein regulation	Patent 11629340 was granted and assigned to Obsidian Therapeutics on April, 2023 by the United States Patent and Trademark Office.	Obsidian Therapeutics	Obsidian Therapeutics	United States Patent and Trademark Office	11629340	April 18, 2023
‌ US Patent 11446398 Regulated biocircuit systems	Patent 11446398 was granted and assigned to Obsidian Therapeutics on September, 2022 by the United States Patent and Trademark Office.	Obsidian Therapeutics	Obsidian Therapeutics	United States Patent and Trademark Office	11446398	September 20, 2022
‌ US Patent 11666642 PDE5 compositions and methods for immunotherapy	Patent 11666642 was granted and assigned to Obsidian Therapeutics on June, 2023 by the United States Patent and Trademark Office.	Obsidian Therapeutics	Obsidian Therapeutics	United States Patent and Trademark Office	11666642	June 6, 2023